These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 23505910

  • 1. Circadian rhythm of serum phosphate, calcium and parathyroid hormone levels in hemodialysis patients.
    Micozkadioglu H, Ozelsancak R, Yildiz I, Erken E, Zumrutdal A, Torun D, Haberal M.
    Clin Lab; 2013; 59(1-2):79-84. PubMed ID: 23505910
    [Abstract] [Full Text] [Related]

  • 2. Effect of CAPD and hemodialysis on parathyroid function.
    Malberti F, Corradi B, Imbasciati E.
    Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912
    [Abstract] [Full Text] [Related]

  • 3. Effect Modifying Role of Serum Calcium on Mortality-Predictability of PTH and Alkaline Phosphatase in Hemodialysis Patients: An Investigation Using Data from the Taiwan Renal Registry Data System from 2005 to 2012.
    Lin YC, Lin YC, Hsu CY, Kao CC, Chang FC, Chen TW, Chen HH, Hsu CC, Wu MS, Taiwan Society of Nephrology.
    PLoS One; 2015; 10(6):e0129737. PubMed ID: 26107510
    [Abstract] [Full Text] [Related]

  • 4. Calcium, phosphate, and PTH levels in the hemodialysis population: a multicenter study.
    Gallieni M, Cucciniello E, D'Amaro E, Fatuzzo P, Gaggiotti A, Maringhini S, Rotolo U, Brancaccio D, Collaborating nephrologists of the CARDIALISI Study Group.
    J Nephrol; 2002; 15(2):165-70. PubMed ID: 12018633
    [Abstract] [Full Text] [Related]

  • 5. Circadian variation of mineral and bone parameters in end-stage renal disease.
    Trivedi H, Szabo A, Zhao S, Cantor T, Raff H.
    J Nephrol; 2015 Jun; 28(3):351-9. PubMed ID: 25138650
    [Abstract] [Full Text] [Related]

  • 6. Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQI ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients.
    Mazzaferro S, Pasquali M, Farcomeni A, Vestri AR, Filippini A, Romani AM, Barresi G, Pugliese F.
    Nephrol Dial Transplant; 2008 Jul; 23(7):2319-23. PubMed ID: 18281320
    [Abstract] [Full Text] [Related]

  • 7. Risk factors and risk for mortality of mild hypoparathyroidism in hemodialysis patients.
    Guh JY, Chen HC, Chuang HY, Huang SC, Chien LC, Lai YH.
    Am J Kidney Dis; 2002 Jun; 39(6):1245-54. PubMed ID: 12046038
    [Abstract] [Full Text] [Related]

  • 8. RenaGel, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone. The RenaGel Study Group.
    Slatopolsky EA, Burke SK, Dillon MA.
    Kidney Int; 1999 Jan; 55(1):299-307. PubMed ID: 9893140
    [Abstract] [Full Text] [Related]

  • 9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 10. Serum phosphate and calcium should be primarily and consistently controlled in prevalent hemodialysis patients.
    Taniguchi M, Fukagawa M, Fujii N, Hamano T, Shoji T, Yokoyama K, Nakai S, Shigematsu T, Iseki K, Tsubakihara Y, Committee of Renal Data Registry of the Japanese Society for Dialysis Therapy.
    Ther Apher Dial; 2013 Apr; 17(2):221-8. PubMed ID: 23551679
    [Abstract] [Full Text] [Related]

  • 11. Circadian rhythm in serum parathyroid hormone concentration in human subjects: correlation with serum calcium, phosphate, albumin, and growth hormone levels.
    Jubiz W, Canterbury JM, Reiss E, Tyler FH.
    J Clin Invest; 1972 Aug; 51(8):2040-6. PubMed ID: 5054463
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Increase of nocturnal melatonin levels in hemodialyzed patients after parathyroidectomy: a pilot study.
    Kancheva R, Sulková S, Švára F, Hill M, Kanchev L, Žofková I.
    Physiol Res; 2008 Aug; 57 Suppl 1():S181-S185. PubMed ID: 18271678
    [Abstract] [Full Text] [Related]

  • 14. Relation between serum calcium, phosphate, parathyroid hormone and 'nondipper' circadian blood pressure variability profile in patients with normal renal function.
    Kanbay M, Isik B, Akcay A, Ozkara A, Karakurt F, Turgut F, Alkan R, Uz E, Bavbek N, Yigitoglu R, Covic A.
    Am J Nephrol; 2007 Aug; 27(5):516-21. PubMed ID: 17703091
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The differences in acid-base status and the calcium parathyroid axis between peritoneal dialysis and hemodialysis.
    Morishita M, Matsuo N, Maruyama Y, Nakao M, Yamamoto I, Tanno Y, Ohkido I, Ikeda M, Yokoyama K, Yokoo T.
    Clin Nephrol; 2016 Aug; 86(2):55-61. PubMed ID: 27345183
    [Abstract] [Full Text] [Related]

  • 19. Evidence that serum phosphate is independently associated with serum PTH in patients with chronic renal failure.
    Kates DM, Sherrard DJ, Andress DL.
    Am J Kidney Dis; 1997 Dec; 30(6):809-13. PubMed ID: 9398125
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.